Alumni Spotlight

Thursday, September 21

Pear Therapeutics, a tech company specializing in Digital Therapeutics, secures FDA approval for the first substance abuse treatment app. Pear's President & CEO, Corey McCann−2009 WUSTL MSTP alumnus−​explains that the app, reSET®, "has demonstrated improved abstinence and treatment retention in a randomized controlled clinical study." Read Pear's press release here. The technology was also recently featured in a CNBC tech article​.

Corey entered the MSTP in 2001, after earning a B.S. in Biology from Penn State. He completed a Ph.D. in Neurosciences, under the co-direction of Dr. Joshua Sanes and Dr. Jeff Lichtman. Following graduation of the MD-PhD degree in 2009, he took a position at the management consulting firm, McKinsey & Company.

Back to top